What Is Coxiella Burnetii? The Bacterium Behind Q Fever

Coxiella burnetii is a bacterium that causes Q fever, a disease humans typically catch by breathing in contaminated dust from infected livestock. It belongs to a unusual category of bacteria that can only survive and reproduce inside the cells of a host, making it an obligate intracellular pathogen. What makes it particularly notable is its extraordinary ability to persist in the environment and resist conditions that would kill most other bacteria.

Basic Biology

C. burnetii is a gram-negative coccobacillus, meaning it’s a small, oval-shaped bacterium. Unlike nearly all other disease-causing bacteria, it thrives in the harshly acidic interior of a specific compartment inside immune cells called the phagolysosome. This is the very compartment your immune cells use to digest and destroy invaders, with a pH between 4 and 5 (roughly as acidic as tomato juice). C. burnetii not only survives there but actually needs that acidity to activate its metabolism and begin reproducing.

Once inside a host cell, the bacterium creates a large, specialized pocket called a Coxiella-containing vacuole. It hijacks the cell’s own recycling systems to funnel nutrients and membrane material into this vacuole, effectively building itself a protected habitat. It does this by injecting dozens of specialized proteins into the host cell that redirect the cell’s normal processes to serve the bacterium’s needs.

Two Forms, Two Jobs

C. burnetii switches between two distinct physical forms depending on where it is in its life cycle. Inside a host cell, it exists as a large cell variant (LCV), which is the active, dividing form. LCVs are irregularly shaped and typically longer than 1 micrometer, with loosely organized DNA and active metabolism.

When conditions signal that it’s time to leave the host cell, the bacterium transforms into a small cell variant (SCV). SCVs are compact, rod-shaped, and only 0.2 to 0.6 micrometers long. Their DNA is tightly condensed, and they contain unusual stacks of tightly packed membranes in their interior. SCVs don’t replicate, but they are extraordinarily tough. Although not a true bacterial spore, the SCV form resists heat, drying, UV light, and chemical disinfectants in ways that most non-spore-forming bacteria cannot. This durability is the key reason C. burnetii spreads so effectively through the environment: SCVs can persist in soil and dust for extended periods, waiting to be inhaled by a new host.

How It Spreads to Humans

Domestic livestock are the primary source of human infections. Goats, cattle, and sheep are the most common reservoirs, though dogs and cats can also carry the bacterium. C. burnetii has a particular affinity for the uterus and mammary glands of female animals, where it establishes chronic infections. When an infected animal gives birth or miscarries, it sheds enormous quantities of bacteria into the surrounding environment through birth fluids, placental tissue, and amniotic fluid.

Those bacteria, in their hardy SCV form, dry out and become part of the dust. The primary route of human infection is inhaling this contaminated dust, sometimes from considerable distances downwind of a farm. Infection can also occur through consuming unpasteurized milk or cheese from infected animals, though this is less common. Person-to-person transmission is rare.

Who Is Most at Risk

Q fever is fundamentally an occupational disease. People who work closely with livestock, especially during birthing season, face the highest exposure. A cross-sectional study of multiple professions found that 77% of shepherds, 70% of cattle farmers, and 64% of veterinarians showed antibodies against C. burnetii, indicating past or current infection. Slaughterhouse workers also carry high rates, with studies reporting seroprevalence between 30% and 70%. Even office workers at agricultural facilities showed elevated rates (41%) compared to the general population, likely from environmental exposure on farm premises.

Q Fever: Acute Infection

About half of people infected with C. burnetii develop no symptoms at all. Those who do get sick typically experience an illness that looks like a bad flu, appearing roughly two to three weeks after exposure. Common symptoms include high fever, severe headache, fatigue, muscle pain, chills, sweats, and cough. Some people also develop nausea, vomiting, diarrhea, or chest pain. The combination and severity varies widely from person to person.

Most people recover completely. A smaller number develop more serious complications including pneumonia, liver inflammation with granulomas, heart muscle inflammation, or neurological problems. Pregnant women face particular risks even if they have no symptoms: infection during pregnancy is associated with miscarriage, stillbirth, preterm delivery, and low birth weight.

Chronic Q Fever

In a small percentage of cases, the infection doesn’t clear and instead transitions to a chronic form that can emerge months or even years later. The most dangerous manifestation of chronic Q fever is endocarditis, an infection of the heart valves. Left untreated, it is fatal. Other chronic forms can affect the bones, liver, blood vessels (particularly existing aneurysms), and reproductive organs. People with pre-existing heart valve problems or weakened immune systems are at the greatest risk of developing chronic disease.

Diagnosis

Diagnosing Q fever can be tricky because its symptoms overlap with many common illnesses. The gold standard is a blood antibody test using a method called indirect immunofluorescence assay (IFA). Doctors look for a fourfold rise in specific antibodies between a blood sample taken during the first week of illness and a second sample drawn three to six weeks later. This delay means the diagnosis is often confirmed well after treatment has already started.

For earlier detection, a PCR test on blood can identify the bacterium’s genetic material very early in the illness, often before antibodies develop. However, the PCR test becomes unreliable once antibodies rise or after antibiotics are given. This creates a narrow diagnostic window where PCR works best in the first days of symptoms, before treatment begins.

Treatment

Acute Q fever is treated with a two-week course of the antibiotic doxycycline. When started early, this is highly effective and most people recover fully. Chronic Q fever is a far more demanding problem. The standard treatment combines doxycycline with hydroxychloroquine (a drug that raises the pH inside cells, making the bacterium’s acidic hiding spot less hospitable). This combination must be continued for at least 18 months for patients with natural heart valves, and 24 months for those with prosthetic valves. Regular monitoring throughout treatment is necessary because the infection can relapse.